Catheter Precision, Inc.
VTAK
$0.2848
-$0.0352-11.00%
AMEX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 149.00K | 96.00K | 93.00K | 82.00K | 128.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 149.00K | 96.00K | 93.00K | 82.00K | 128.00K |
| Cost of Revenue | 11.00K | 10.00K | 16.00K | 5.00K | 7.00K |
| Gross Profit | 138.00K | 86.00K | 77.00K | 77.00K | 121.00K |
| SG&A Expenses | 3.10M | 2.88M | 2.71M | 2.66M | 2.73M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.20M | 2.96M | 2.81M | 2.70M | 2.73M |
| Operating Income | -3.05M | -2.86M | -2.72M | -2.62M | -2.60M |
| Income Before Tax | -2.49M | -4.12M | -4.22M | -2.68M | -669.00K |
| Income Tax Expenses | 3.14M | -- | -- | -- | -- |
| Earnings from Continuing Operations | -5.63M | -4.12M | -4.22M | -2.68M | -669.00K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -5.63M | -4.12M | -4.22M | -2.68M | -669.00K |
| EBIT | -3.05M | -2.86M | -2.72M | -2.62M | -2.60M |
| EBITDA | -2.52M | -2.33M | -2.19M | -2.09M | -2.08M |
| EPS Basic | -1.14 | -2.01 | -5.57 | -3.60 | -0.95 |
| Normalized Basic EPS | -0.16 | -1.26 | -3.48 | -2.25 | -0.59 |
| EPS Diluted | -1.14 | -2.01 | -5.57 | -3.60 | -0.95 |
| Normalized Diluted EPS | -0.16 | -1.26 | -3.48 | -2.25 | -0.59 |
| Average Basic Shares Outstanding | 9.49M | 2.05M | 757.30K | 742.90K | 703.90K |
| Average Diluted Shares Outstanding | 9.49M | 2.05M | 757.30K | 742.90K | 703.90K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |